Researchers from Keio University School of Medicine and Osaka University, including RegCell Inc.’s scientific founder and co-winner of the 2025 Nobel Prize in Physiology or Medicine, Shimon Sakaguchi, published a pair of Science Translational Medicine papers showing that effector T cells can be turned into regulatory T cells that are functional, stable and capable of suppressing an autoimmune skin disorder in mice.
